Benchling

Biotech R&D Platform Benchling Closes $100M at $6B Valuation

What You Should Know: Biotech R&D platform Benchling raises $100M at a $6B valuation, co-led by Franklin Templeton and Altimeter Capital to expand product development and global footprint, particularly in EMEA. More than 200,000 scientists at over 600 companies and 7,000 research institutions globally have adopted Benchling’s R&D Cloud to make breakthrough discoveries and bring …

Biotech R&D Platform Benchling Closes $100M at $6B Valuation Read More »

Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform

– Today Benchling, the leading life and sciences R&D cloud, announced a $200M Series E raise led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital, and Elad Gil. This funding will be used to aggressively invest in product development and global expansion to support enterprise customers. The raise is also joined …

Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform Read More »